In the US, Canakinumab (canakinumab systemic) is a member of the drug class interleukin inhibitors and is used to treat Cryopyrin-Associated Periodic Syndromes, Familial Cold Autoinflammatory Syndrome, Familial Mediterranean Fever, Hyperimmunoglobulin D Syndrome, Juvenile Idiopathic Arthritis, Muckle Wells Syndrome and Tumor Necrosis Factor Receptor Associated Periodic Syndrome.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Immunoglobulin G1, anti-[Homo sapiensinterleukin 1, beta (IL1B)] human monoclonal ACZ885; gamma1 heavy chain (Homo sapiensVH-IGHG1*03) (221-214)-disulfide with kappa light chain (Homo sapiensV-KAPPA-IGKC*01); (227-227:230-230 (WHO )
- Canakinumabum (Latin)
- Canakinumab (German)
- Canakinumab (French)
- Canakinumab (Spanish)
- Canakinumab (OS: USAN, BAN)
- Canakinumab (Genetical Recombination) (OS: JAN)
- ACZ885 (IS)
- UNII-37CQ2C7X93 (IS)
Novartis, Argentina; Novartis, Belgium; Novartis, Czech Republic; Novartis, Denmark; Novartis, France; Novartis, Greece; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Israel; Novartis, Lithuania; Novartis, Netherlands; Novartis, Norway; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis, Slovakia; Novartis, United States; Novartis Europharm, Austria; Novartis Europharm, Slovenia; Novartis Farma, Italy; Novartis Farmaceutica, Spain; Novartis Healthcare, Philippines; Novartis Pharma, Switzerland; Novartis Pharma, Germany; Novartis Pharma, Russian Federation; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals UK, United Kingdom
|BAN||British Approved Name|
|JAN||Japanese Accepted Name|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.